Iambic Therapeutics is a biotechnology company focused on developing innovative therapies for neurodegenerative diseases. The company leverages advanced artificial intelligence and machine learning technologies to enhance drug discovery and development processes. Iambic Therapeutics aims to address unmet medical needs in conditions such as Alzheimer's disease and other cognitive disorders by creating targeted treatments that improve patient outcomes. Their approach combines cutting-edge research with a commitment to scientific excellence and collaboration within the healthcare ecosystem.